Birinapant and Intensity Modulated Re-Irradiation Therapy for Local-Regionally Recurrent Head and Neck Squamous Cell Carcinoma

Conditions:   Head Cancer;   Facial Cancer;   Neck Cancer;   Upper AerodigestiveTract Cancer;   Oral Cancer Interventions:   Drug: Birinapant;   Radiation: Intensity modulated re-irradiation therapy (IMMRT) Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials